GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sanofi SAN.PA · EUR

Health Care · Pharmaceuticals · Euronext Paris · 🇫🇷 France

Euro Stoxx 50

Compare

85.76

+2.41%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Sanofi — daily SAN

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Sanofi on TradingView ↗
Market value
€102.96bn
Last close × shares
Volume
2.9m
Shares, 9 Nov 2026
Price to earnings
20.6
Dividend yield
4.90%

About Sanofi

Its shares trade on Euronext Paris under the ticker SAN.PA. It has been listed since 1 July 2002. It is a member of the Euro Stoxx 50. In the fiscal year to 31 December 2025, it reported revenue of €46.72bn and net income of €7.81bn. At that date it held total assets of €126.81bn and shareholders' equity of €71.38bn.

Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.

Figures and description from our data supplier, not checked against the company's own report.

More about Sanofi →

Latest on Sanofi

Our reporting

Next results

28 Jan 2027

Due on 28 Jan 2027. Analysts expect earnings of 1.70 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Sanofi's ticker?

Sanofi trades as SAN.PA on Euronext Paris, under ISIN FR0000120578.

What was Sanofi's last closing price?

85.76 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Sanofi next report results?

Results are expected on 28 Jan 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.